Form 4: MAXIMUS Director Michael J. Warren Reports Acquisition of Common Stock and Dividend Equivalent Rights
SEC Form 4 Filing
Director Michael J. Warren reports purchasing MAXIMUS common stock through dividend reinvestment and acquiring dividend equivalent rights.
Summary
- On February 28, 2025, Michael J. Warren, a director of MAXIMUS, INC., acquired 18.387 shares of common stock through dividend reinvestment at a price of $66.645 per share.
- This purchase increased Warren's direct ownership to 4,103.06 shares.
- Warren also acquired 41.517 dividend equivalent rights related to previously awarded restricted stock units (RSUs).
- These dividend equivalent rights vest proportionately with the RSUs and are economically equivalent to one share of MAXIMUS common stock each, bringing the total to 9,064.607 dividend equivalent rights.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. The director's participation in dividend reinvestment suggests confidence in the company's future, but the filing itself is a routine disclosure.
Positives
- The acquisition of shares through dividend reinvestment indicates a continued investment and confidence in MAXIMUS by a director.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential sentiment.
Comparison to Industry Standards
- Monitoring insider transactions is a common practice in financial analysis.
- Comparing the trading activity of MAXIMUS insiders to those of similar companies in the government services sector (e.g., Leidos, Booz Allen Hamilton) can provide insights into relative valuation and management confidence.
- Dividend reinvestment programs are a fairly standard offering among publicly traded companies.
Stakeholder Impact
- The transaction has a minimal direct impact on stakeholders.
- It provides transparency to shareholders regarding insider transactions.
Key Dates
| Date | Description |
|---|---|
| 02/28/2025 | Date of transaction: acquisition of common stock and dividend equivalent rights. |
| 03/04/2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.